Marsh & McLennan stock fell 1.04 percent as JPMorgan raised its target

Published on 10/03/2026 at 22:54 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Marsh & McLennan stock faces a USD 215 JPMorgan target after the bank raised it from USD 212 on October 1, 2026. Fiscal Q3 EPS is forecast at USD 1.96.

Pop-Art-Comic zeigt Handschlag zwischen Berater und Kunde mit Sprechblase DEAL — Marsh & McLennan (ISIN US5717481023) als farbenfrohe Pop-Art-Comic-Szene eines Versicherungsberaters beim Vertragsabschluss, Illustration mit AI erstellt.

Marsh & McLennan stock (ISIN US5717481023) fell 1.04 percent to USD 170.06 on the NYSE on October 2, 2026, as investors weighed a higher JPMorgan target against a weak recent trading trend. The stock's 52-week range is USD 156.60 to USD 207.83, placing the latest price 18.2 percent below the yearly high.

JPMorgan lifts target to USD 215

According to Markets Insider on October 1, 2026, JPMorgan raised its price target from USD 212 to USD 215 and retained an Overweight rating. The new target lies 26.4 percent above the October 2 price, while the unchanged rating gives the call a constructive tone despite the share decline.

The broader analyst picture is less uniform. Yahoo Finance reported on September 30, 2026, that the average price target stood at USD 203.91, implying 19.9 percent upside from the latest market price.

Q3 forecast points to October 15

For fiscal Q3 2026, analysts forecast adjusted EPS of USD 1.96, up from USD 1.85 in the year-ago quarter, according to Yahoo Finance. The same report puts fiscal 2026 adjusted EPS at USD 10.44, versus USD 9.75 in fiscal 2025, a 7.1 percent increase.

MarketScreener reported on September 17, 2026, that Marsh will release fiscal Q3 results before the market opens on October 15, 2026, followed by an investor call at 8:30 a.m. EDT. That date is the next scheduled test for the earnings outlook.

Stock remains below its yearly high

Marsh & McLennan's market capitalization was USD 81.2 billion on October 2, 2026, with volume of 2,921,503 shares. The combination of a USD 215 target, a 19.9 percent consensus upside indication and a price 18.2 percent below the 52-week high gives investors a clear split between valuation support and recent market pressure.